Azabicyclooctan-3-one derivatives and use thereof

Details for Australian Patent Application No. 2005223728 (hide)

Owner Aprea AB

Inventors Westman, Jacob; Wiman, Klas; Bykov, Vladimir; Selivanova, Galina

Agent Davies Collison Cave

Pub. Number AU-B-2005223728

PCT Pub. Number WO2005/090341

Priority 0400708-4 22.03.04 SE

Filing date 22 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 10 February 2011

International Classifications

C07D 453/00 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 491/20 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/090341 Priority application(s): WO2005/090341

10 February 2011 Application Accepted

  Published as AU-B-2005223728

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223729-Novel amination process

2005223727-N-piperidine derivates as CCR3 modulators